Sveta Karelsky, MD
Otolaryngology · Rochester, NYNPI 1265453328
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $70,088 of the $100,623 with a category attached, or 69.7%. Every reported general payment came from a single manufacturer, Inspire Medical Systems, Inc.. Reporting peaked in 2024 at $37,669 and has fallen 52.5% since, to $17,875 in 2025. Among otolaryngology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 118 payments — averaging $852.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$101K
Across 4 payments — averaging $2533.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inspire Medical Systems, Inc.$10K
What the payments were for
- Consulting fees$70,08870%
- Speaking & faculty fees$16,00016%
- Travel & lodging$10,57311%
- Food & beverage$3,9634%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 118 | $100,623 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$86,231
- Inspire Upper Airway Stimulation System$12,863
How this compares
$100,623 in reported general payments places this provider in the 95th percentile of 701 otolaryngology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 58 | $1,307 |
| Azelastine Hcl | 31 | $798 |
| Fluticasone Propionate | 40 | $493 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Rochester
- Li-Xing ManRochester$52K
- Timothy DoerrRochester$28K
- Benjamin CraneRochester$11K
- Robert KellmanSyracuse$2.5M
- Roheen RaithathaNew York$830K
- Nora PerkinsAlbany$300K
- Moshe EphratNew Hyde Park$250K
- Gavin SetzenAlbany$243K
- Habibullah JamalRye Brook$179K
- Albert JenFlushing$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.